A method for detecting serum miRNAs in cancer patients based on short nucleotide chain ligation
A short nucleotide and chain connection technology, which is applied in biochemical equipment and methods, microbial measurement/inspection, etc., can solve the problems of complex operation, hindering clinical application, high cost of detection specificity and detection throughput, and achieve operational Easy to use, accurate and reliable detection results, high sensitivity and specificity
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
specific Embodiment 1
[0034]A method for detecting serum miRNA in cancer patients based on short nucleotide chain ligation, the establishment and optimization of high-throughput SOL-based technology for detecting serum miRNA: pretreatment of serum samples, and capture sequence, nucleic acid probe 1, nucleic acid Probe 2, signal amplification sequence hybridization, and then use SA-HRP to catalyze the chemiluminescent substrate solution to generate strong fluorescence, and determine the expression level of target miRNA in serum by detecting the fluorescence intensity; systematically optimize serum processing time, nucleic acid hybridization temperature, signal Amplify the number of Biotin on the sequence and other conditions, and establish a new method for miRNA detection with strong specificity, accurate and reliable results, and easy operation. miRNA; at the same time, using this miRNA detection method to detect miR-16 and miR-21 in the serum samples of 20 cases of healthy controls and 34 cases of ...
specific Embodiment 2
[0036] A method based on short nucleotide chain ligation to detect serum miRNA in cancer patients, using SOL technology to detect specific miRNA markers in serum for early diagnosis of lung cancer: using a new method of SOL detection combined with well-explored serum pretreatment methods, Two miRNAs, miR-16 and miR-21, were detected in the serum samples of 20 healthy controls and 34 NSCLC patients of different stages, ages and genders; miR-16 with relatively stable expression was used as an internal reference substance, and miR-21, which was specifically highly expressed in the serum of NSCLC patients, was used as a miRNA marker. Fluorescent quantitative PCR was used to detect miR-16 and miR-21 in the collected serum samples, and the Ct value detected by miR-21 was normalized with the Ct value of the internal reference miR-16. The multiples are expressed by 2-ΔCt, see Table 1-2.
[0037] Table 1 Real-time quantitative PCR detection of Ct values of miRNAs in the serum of hea...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com